Kura Oncology, Inc. ( KURA) - Stock Earnings
KURA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
KURA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -81.0 million USD | 17.3 million USD |
| 2026Q1 | -73.3 million USD | 18.3 million USD |
| 2026Q2 | -68.3 million USD | 20.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
KURA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -152.6 million USD | — USD |
| 2024 | -174.0 million USD | 53.9 million USD |
| 2025 | -278.7 million USD | 67.5 million USD |
| 2026 Est. | — | — |
KURA
Price: $9.08
52 week price:
Earnings Per Share: -3.50 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 495600
Ebitda: -9.1 millionMarket Capitalization: 940.1 million